Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.0%
    Check dated 2024-09-04T06:36:18.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Recent updates include new entries from August 21 to August 26, while previous updates from August 16 to August 20 have been removed.
    Difference
    0.2%
    Check dated 2024-08-28T03:42:27.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    Recent additions include dates from mid to late August 2024, while several earlier dates from June to August 2024 have been removed.
    Difference
    0.3%
    Check dated 2024-08-21T02:28:38.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.2, with the last update posted on August 10, 2024, while the previous version v2.10.0 and updates from August 1 and 2, 2024, have been removed.
    Difference
    0.3%
    Check dated 2024-08-14T01:12:46.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    New dates added for August 2024, while previous entries from late June and early July 2024 have been removed.
    Difference
    0.6%
    Check dated 2024-08-07T00:09:15.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-31T00:05:02.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.